Coronary perforation: An unreported complication after intracoronary stent implantation  by Benzuly, Keith H. et al.
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0.0001). Also, no relationship be~Jeen FC and culpdt stenosis (measured by 
quantitative angtography) was found (r = 0.17, p = 0.3). Thallium score was 
similar in pts with TIMI II (1.3:1: 0.8) and TIMI fll flow (1.2 • 0.8, p = 0.9). 
Conclusion: Angiographlc assessment of myocardial porfusion in the in- 
fact related artery does not correlate with ecintigraphic assessment of my- 
ccardial viability and, therefore, does not appear to otter an advantage com- 
pared to TIMI flow grading. 
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~ Initial and Six Months Outcome of Palmaz-Schatz 
Stsnt Implantation: STRESSIBenestsnt Equivalent 
Vs Non-equivalent Lesions 
Yoshihiro Saweda, Hidayuki Nosaka, Takashi Kimura, Masaklyo Nobuyoshi. 
ICitakyushu, Kokura Memorial Hospital, Japan 
To assess efficacy of the Palmaz-Schatz stent (PS) for lesions (las) currently 
exctuded from randomized trials, the immediate and 3-6 months (M) fo,ow 
up (FU) results were compared between Stress/Benestent (S/B) equivalent 
les (n = 152) and Nen-S/B las (n = 593): Small vessel (Ref. D < 3.0 mm, n = 
236), Long los (length > 15 mm, n = 125), Ostial lee (n = 97), Total occlusion 
(n = 40), Vein graft (n = 52). Rastenotic les (n = 301), Poor LV (n: 96). Before 
Jut. 1994, 700 patients (pts) (745 le.) undenNant PS implantation and 3-6 M 
FU quantitative angiogrephy was performed in 689 lee (93%). 
SAT D/G/M Rsste. TLR MLD (mm) 
(%) (%) (%) (%) pro post FU 
S/8 Equiv- 
alent 1.3 6.6 11 8.0 O.9:EOA 3.0:J:0.4 2.3±0.6 
Non-S/B 
Small 1.5 8.0 30* 19" 0.74-0.4* 2.6+0.4* 1.7:1:0.7" 
Long %6 4,8 32* 15 0.6~0.5" 2.84-0.6* 1.94-0.9" 
Ostlal 2.1 11" 40* 14 0.7±0.5* 2.9~0.5 ° 1.8"1"1.0 * 
Total 0 2.5 40 ° 7.5 O.0±0.1* 2.7~:0.7' 1.6:~0.9 ° 
Vein 0 5.8 .°,4" 21" 0.9-1-0.6 3.2:E0.5" 2.1~1.1 
Rests. 1 4.0 27* 15" 0.8±0.4 ° 2.9~0.5" 1.9:1:0.8 ° 
PoorLV 3.1 14 19 14 0.7-~0.5" 3.08-0.5 2.1 ±0.8 
SAT: .qubacute hrombosis. D/C/M: Death/CABG/MI at 7 M. Reste: Binary restenosls at 7 
M. TLR: Target lesion revassularizntion at 7 M. °p < 0.05 compared with Stmss/Benestent 
Equivalent los. 
Conclusion: S/B equivalent los constituted relatively small fraction of los. 
treated in clinical practices. Immediate results of Non-S/B equivalent los were 
similar to those of S/B equivalent las. However, FU results of Non-S/S lesion 
were not comparable to those of S/B les. 
~ Coronary An Unreported Complication Perforation: 
After Intracoronary Stent Implantation 
Kalth H. Banzuly, Sue Glazier, Cindy L. Gdnas, William W. O'Neill, Robert 
D. Safian, William Beaumont Hospital, Royal Oak MI 
Coronary artery perforation isan uncommon complication after pemutanecus 
intervention, and has not been reported after slant Implantation. To determine 
the incidence of perforation associated with stsnting, we reviewed all stsnt 
p;ocedures between September, 1993 and May 31, 1995. Among 928 stsnts 
deployed in 435 patient here were 10 perforations (2.3%; 6 Palmaz-Schatz, 
2 b11iary, 4 Giantumo-Roubin). Stsnt implantation was planned in 3 cases 
and unplanned in 7 cases (due to severe dissections after another device). 
Anglogrephlo features associated with perforation i cluded ACC/AHA B2 or C 
lesion morphology (80%); small vessel dlametsr (2,6 :l: 0,2 ram); oversized 
slants (StentJArtery ratio 1,4 4- 0.1); tapering vessel (40%); and need to 
recross a dissection with a guldewire (20%). Major clinical sequelae included 
cardiac tamponede (50%), myocardial infarction (40%), emergency surgery 
(50%), and death (30%). Two cases of tamponede occurred between 5-24 
hours after stent deployment in patients without angiographic evidence of 
perforation. 
In conclusion: Coronary perforation is uncommon after stent implantation 
but may occur in the setting of antecedent severe dissection in small vessels 
treated with oversized stsnts. Careful attention to stent size and avoiding 
high pressure inflations outside the stent may prevent stent-pedoretion. 
~ Coronary Stsnting Elderly Patients. Results In 
From the Stent Without Coumsdin French Registry 
Thlemj Lefbwe, Made-claude Modce, Bernard Labronie, Yves Chabdl;at, 
Yves Gu6dn, Remy Pillibre, Yves Louvard, Max Amor, C--,aGtsn Kadllon, 
Edgar Benvenists. ICV Paris Bud, France 
To evaluate the results of coronary stent placement in aldedy patients, a 
retrospective analysis of the 2901 Pts (mean age: 61.2 + 10.6 years) included 
from March 1991 to March 1995 in the Stent Without Coumadin French 
RegisW was performed. 
Tictopldine (250-500 mg/day) was given Ihe day of PTCA for 1 month, 
aapidn (100-250 rag/day) for > 6 months and low molecular weight hepadn 
(antiXa 0.5-1) for 1 month in phase II (237 Pts), 15 days in phase III (521 
Pts), 7 d~ys in phase IV (960 Pts) and not given in phase V (1183 Pts). 
The study group include 245 Pts (8.4%) aged ~ 75 years. Nineteen % 
were female, 49% had unstable, 8% Post M.I ischemla, 2"/0 acute M.I and 
41% stable angina. Indication for stenting was respectively: de novo lesion 
(27%), restenosts (17%), suboptimal result (2~), non occlusive dissection 
(24%) and occlusive dissection (11%). Stented coronary artedas were LAD: 
44%, RCA: 33%, Cx: 10%, L.M: 2% and Bypass: 2%). Palmaz-Schatz stents 
were used in 79% of cases, AVE stents in 16% and other stonts in 5%. One 
stent was used in 80% of cases and more than 1 in 20%. Balloon used for 
slanting was 3.32 -I- 0.38 mm in diameter with a mean inflation pressure of 
12,3:1:3.0 aim. At 1 month follow-up, vascular complication occurred in 2% 
of cases (requidng surgery in 1.2%), acute closure in 0.4%, subacute closure 
in 1.6%, emergency CABG in no case, acute M.I in 1.6%, stroke in 0.4% 
and Geath in 3%. The composite nd-point of subacute closure, acute M.I., 
CABG and death occurred in 5% of cases. 
In conclusion: coronary stsnting without coumadin seems to be a safe 
approach in eldedy patients. 
[975"~ Coronary Angioplesty Versus Primary Stent 
Placement for Isolated Proximal Left Anterior 
Descending Coronary Artery Stenesls 
Achille Gaspardone, Francesco Versact, Fabdzio Tomai, Anna De Fazio, 
Giovanni Colantuono, Mada lamele, Pier A. Gioffr& Divisione di 
Cardiochlrurgia, Universit~ Tot Vergata, Rome, Italy 
P,oximal left antedor descending coronary artery (LAD) stsnosis cardas a 
poor prognosis. Coronary angioplasty (PTCA) has been shown to be a suit- 
able alternative to left internal mammary artery grafting which is considered 
to be the standard treatment. However, no data are available concerning pd- 
mary stsnt (S) placement. To this end we have carded out a prospective study 
aimed at compadng the efficacy of PTCA or S placement in the treatment of 
patients (pts) with isolated proximal LAD stenosis. Eligible pts were randomly 
assigned to PTCA (56 pts; mean age 57:1:10 ym) or S (Palmaz-Schatz) 
placement (60 pie; 57 :J: 9 yre). Pro-intervention clinical and hemodynamic 
variables did not differ between groups. Follow-up anglograms were obtained 
in 80%o f PTCA-treated 10ts and in 87% of S-treated pts. Procedure and early 
and 12-month clinical outcomes were as follows (mean values): 
PTCA S 
Vessel diameter ( am) 3.1 3.2 NS 
Baseline % diameter stenosis 92 91 NS 
Rnal % diameter tenosls 20 3 p = 0.001 
Procedure success (%) 95 97 NS 
In-hospital complication (%) 0 6 NS 
12-monlh restanosis rata (%) 40 19 p = 0.04 
12-month event-free survival (%) 69 90 p = 0.02 
Thus, the findings of this study indicate that, in symptomatic pts with 
proximal LAD stsnosis, primary S placement, compared to PTCA, showed: 
1) a superior initial angiogrephic result; 2) a lower 12-month restenosis rate 
and 3) a more favorable 12-month clinical outcomes. 
~ 1  Rotational Atherectomy Prior to Stsnt Implantation 
Ermlnia M. GuamerL Shela L. Norman, K. Michelie Stevens, 
Oscar Mathews, Richard A. Schatz, Paul S. Teirstsin. Scripps Clinic and 
Research Foundation, La Jolla, CA 
The safety and efficacy of Palmaz-Schatz stents for the treatment of subop- 
timal rotational therectomy (RA) results or as an adjuvant to RA for calcified 
coronary lesions was assessed in 127 pts. In 50% slants were planned. In 
50% slants were placed for suboptimal RA results. The planned and un- 
planned stent groups were similar in AHA/ACC Lesion Class: B1 25%, B2 
43%, C1 32%, mean distal reference diameter (2.75 mm) and mean lesion 
length (7.453 ram). Vessels treated: LAD 34%, RCA 36%, circumflex 21%, 
protected teit main 7%, unprotected left main 2%. High-pressure (> 16 aim) 
bellonn inflation was performed in all stsnts. Procedural success (< 50% di- 
ameter stenosis without Q-wave MI, bypass surgery or death) was achieved 
